Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.0200 (-1.95%) ($4.9291 - $5.1900) on Sun. Jan. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.94% (three month average) | RSI | 35 | Latest Price | $5.0200(-1.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -1.9% a day on average for past five trading days. | Weekly Trend | EYES declines -4.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EYES price | EYES will decline at least -1.97% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.97% (StdDev 3.94%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $5.55 | 5 Day Moving Average | $5.29(-5.1%) | 10 Day Moving Average | $5.19(-3.28%) | 20 Day Moving Average | $5.55(-9.55%) | To recent high | -31.6% | To recent low | 0% | Market Cap | $N/A | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |